Your browser is no longer supported. Please, upgrade your browser.
MNK Mallinckrodt plc daily Stock Chart
Mallinckrodt plc
Index- P/E- EPS (ttm)-11.97 Insider Own0.60% Shs Outstand89.18M Perf Week48.70%
Market Cap255.95M Forward P/E0.66 EPS next Y4.37 Insider Trans0.00% Shs Float81.87M Perf Month31.05%
Income-1007.20M PEG- EPS next Q1.57 Inst Own96.90% Short Float59.22% Perf Quarter-7.72%
Sales3.16B P/S0.08 EPS this Y72.20% Inst Trans3.58% Short Ratio5.33 Perf Half Y17.14%
Book/sh23.05 P/B0.12 EPS next Y-31.66% ROA-9.60% Target Price3.03 Perf Year-87.83%
Cash/sh8.87 P/C0.32 EPS next 5Y-11.70% ROE-35.70% 52W Range1.00 - 23.90 Perf YTD-17.77%
Dividend- P/FCF0.42 EPS past 5Y-51.60% ROI-10.50% 52W High-87.99% Beta2.70
Dividend %- Quick Ratio1.10 Sales past 5Y1.60% Gross Margin44.90% 52W Low187.00% ATR0.53
Employees3400 Current Ratio1.30 Sales Q/Q-3.60% Oper. Margin-42.90% RSI (14)54.08 Volatility19.30% 28.25%
OptionableYes Debt/Eq2.77 EPS Q/Q69.10% Profit Margin-31.50% Rel Volume1.81 Prev Close2.09
ShortableYes LT Debt/Eq2.44 EarningsFeb 25 BMO Payout- Avg Volume9.10M Price2.87
Recom3.20 SMA2040.10% SMA50-16.75% SMA200-29.52% Volume16,243,331 Change37.32%
Sep-05-19Reiterated BofA/Merrill Underperform $5 → $1
Sep-05-19Downgrade BMO Capital Markets Outperform → Market Perform
Sep-03-19Reiterated Berenberg Sell $5 → $1
Jun-11-19Initiated Barclays Equal Weight
May-31-19Downgrade Piper Jaffray Overweight → Neutral
May-22-19Downgrade Jefferies Buy → Hold
Mar-20-19Initiated SunTrust Hold
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Apr-08-20 12:10PM  Why Mallinckrodt (MNK) is Poised to Beat Earnings Estimates Again Zacks +37.32%
Apr-07-20 11:14AM  Mallinckrodt Starts Rolling BLA Filing for StrataGraft Tissue Zacks +16.76%
10:22AM  Mallinckrodt Stock Is Soaring on Refinancing of Debt
09:46AM  Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes
08:48AM  Are Options Traders Betting on a Big Move in Mallinckrodt (MNK) Stock? Zacks
Apr-06-20 06:45AM  Mallinckrodt Initiates Rolling Submission of Biologics License Application for StrataGraft® Regenerative Skin Tissue to U.S. Food and Drug Administration PR Newswire +5.29%
Apr-01-20 06:45AM  Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications PR Newswire
06:45AM  Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications CNW Group
Mar-19-20 10:03AM  The Coronavirus Outbreak Has Derailed Settlements in the Opioid Litigation +15.74%
Mar-18-20 08:50AM  Mallinckrodt Completes NDA Submission for Kidney Failure Drug Zacks -36.09%
Mar-17-20 08:48AM  The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment Benzinga -6.11%
06:45AM  Mallinckrodt Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration (FDA) for Terlipressin for the Treatment of Patients with Hepatorenal Syndrome Type 1 (HRS-1) PR Newswire
Mar-16-20 02:51PM  Drugmaker Mallinckrodt Gives Creditors Deadline Today on Debt Refinance, Opioid Division Bankruptcy -40.79%
06:18AM  Mallinckrodt's stock plunges on court decision regarding Acthar Gel rebates MarketWatch
06:00AM  Mallinckrodt Confirms Court Decision in Lawsuit Against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) and Provides Update Related to Global Opioid Settlement and Present Financing Activities PR Newswire
Mar-13-20 11:01AM  Coronavirus Drug Development Efforts Pick Up Amid Sell-Off Zacks -12.64%
Mar-12-20 09:35AM  Mallinckrodt Up on New York's Support for Opioid Settlement Zacks +14.10%
07:37AM  The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO Benzinga
06:45AM  Mallinckrodt Evaluates the Potential Role for Inhaled Nitric Oxide to Treat COVID-19 Associated Lung Complications, Engages with Scientific, Governmental and Regulatory Agencies PR Newswire
Mar-11-20 08:03AM  The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment Benzinga +39.27%
06:00AM  Mallinckrodt Provides Update on Proposed Global Opioid Settlement PR Newswire
04:18AM  Stocks - Pepsi Falls in Premarket on Rockstar Buy, Mallinckrodt Rises
Mar-06-20 03:26PM  Edited Transcript of MNK earnings conference call or presentation 25-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
08:35AM  Are Options Traders Betting on a Big Move in Mallinckrodt (MNK) Stock? Zacks
Mar-05-20 06:45AM  Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Immunoglobulin A Nephropathy (IgAN) Published in Kidney International Reports PR Newswire -5.99%
Mar-04-20 07:37AM  The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies Benzinga
06:45AM  Mallinckrodt Announces Publication of New Data on Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Dermatomyositis/Polymyositis Published in Open Access Rheumatology: Research and Reviews PR Newswire
Mar-03-20 02:26PM  Mallinckrodt's stock plunges after report of DOJ suit for alleged underpayment of Medicaid rebates MarketWatch -25.83%
12:16PM  U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid Reuters
Mar-02-20 06:45AM  Mallinckrodt Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration (FDA) for Terlipressin for the Treatment of Patients with Hepatorenal Syndrome Type 1 (HRS-1) PR Newswire
Feb-27-20 06:45AM  Mallinckrodt to Present New Data from two Studies on Acthar® Gel (Repository Corticotropin Injection) Therapy in Multiple Sclerosis (MS) Relapse at Fifth Annual ACTRIMS Forum 2020 PR Newswire
01:18AM  US law/opioids: strong medicine Financial Times
Feb-26-20 02:49PM  Mallinckrodt Gains on Opioid Settlement, Beats on Q4 Earnings Zacks -12.00%
01:18PM  Mallinckrodt gets 'much needed clarity' in $1.6B opioid settlement: Analysts American City Business Journals
05:48AM  Generic drugmakers sold most opioids during overdose crisis MarketWatch
05:00AM  Drugmaker Mallinckrodts Opioid Plan: Sacrifice a Part to Save the Whole Bloomberg
Feb-25-20 04:27PM  Mallinckrodt Unveils $1.6 Billion Opioid Deal And Generic Stocks Pop Investor's Business Daily +13.91%
11:14AM  Stocks tumble Tuesday after suffering their worst day in two years MarketWatch
10:03AM  Mallinckrodt Rips Higher After Company Confirms $1.6B Opioid Litigation Settlement Benzinga
08:56AM  Mallinckrodt Stock Is Soaring After the Company Agreed to Settle Opioid Lawsuits
08:28AM  The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement Benzinga
08:23AM  Mallinckrodt reaches $1.6B opioid settlement calling for generics unit bankruptcy American City Business Journals
08:19AM  Mallinckrodt Stock Soars and Palo Alto Plummets as the Dow Looks Set to Rise
08:05AM  Benzinga Pro's Top 5 Stocks To Watch For Tues., Feb. 25, 2020: NIO, TUP, PANW, MRNA, MNK Benzinga
07:44AM  Mallinckrodt agrees to $1.6 billion opioid settlement, unit to seek bankruptcy Reuters
07:30AM  Mallinckrodt (MNK) Surpasses Q4 Earnings and Revenue Estimates Zacks
07:23AM  Mallinckrodt Surges After $1.6 Billion Opioid Claims Settlement Bloomberg
06:37AM  Mallinckrodt's stock bounces after opioid-related settlement deal, earnings that beat expectations MarketWatch
06:30AM  Mallinckrodt Plc to Host Earnings Call ACCESSWIRE
06:05AM  Mallinckrodt plc Reports Strong Fourth Quarter and 2019 Results PR Newswire
06:00AM  Mallinckrodt Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities PR Newswire
Feb-24-20 03:40PM  Mallinckrodt Shares Plunge Following Bankruptcy Report Bloomberg -18.55%
02:48PM  Mallinckrodt proposes $1.6 billion opioid deal, Chapter 11 for generics unit: WSJ Reuters
02:46PM  Mallinckrodt's stock suffering record selloff after WSJ report of talks with creditors MarketWatch
10:12AM  Why Mallinckrodt (MNK) Might Surprise This Earnings Season? Zacks
Feb-14-20 07:38AM  Mallinckrodt to Report Earnings Results for Fourth Quarter and Fiscal 2019 PR Newswire -8.92%
Feb-10-20 02:43PM  New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA Benzinga
Feb-06-20 03:34PM  4 Stocks Looking Higher During Earnings Season Benzinga
12:10PM  Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report? Zacks
11:17AM  Four stocks to watch this week include Clovis Oncology and 3D Systems MarketWatch
08:40AM  Implied Volatility Surging for Mallinckrodt (MNK) Stock Options Zacks
Jan-22-20 02:48PM  This local regenerative medicine company is plotting its IPO American City Business Journals -7.45%
Jan-20-20 09:30AM  Should Value Investors Consider Mallinckrodt (MNK) Stock? Zacks
08:17AM  J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge Zacks
Jan-15-20 01:55PM  Mallinckrodt's stocks soars on heavy volume toward near-40% gain this week after comments at broker conference MarketWatch +25.42%
Jan-13-20 09:11AM  Endo Up on Opioid Abuse Settlement Agreement With Oklahoma Zacks
Dec-30-19 09:12AM  Will J&J be Able to Overcome Its Legal Troubles in 2020? Zacks
Dec-23-19 06:45AM  Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire -5.21%
Dec-19-19 06:00AM  These Are the Trades That Gutted Bonuses This Year Bloomberg
Dec-17-19 10:25AM  Mallinckrodt Initiates Phase IV Study on Acthar for Keratitis Zacks
Dec-16-19 04:45PM  First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar® Gel (Repository Corticotropin Injection) for Severe Keratitis PR Newswire
Dec-11-19 08:52AM  Implied Volatility Surging for Mallinckrodt (MNK) Stock Options Zacks
Dec-10-19 12:49PM  A Word of Caution for 2 Underperforming Stocks
06:45AM  Mallinckrodt Announces Plans to Update Its Incentive Compensation Clawback Policy and Create Opioid Report PR Newswire
Dec-09-19 10:04AM  Mallinckrodt International Finance SA -- Moody's downgrades Mallinckrodt's CFR to Caa2; considers transaction a distressed exchange Moody's
Dec-07-19 12:05PM  Mallinckrodt Presents Data on a Novel Predictive Model to Identify Infants at Risk for Infantile Spasms (IS) at the 2019 Annual Meeting of the American Epilepsy Society (AES) PR Newswire
Dec-06-19 11:33AM  Two St. Louis companies make list of 15 worst corporate deals American City Business Journals
Dec-05-19 11:31AM  Mallinckrodt (MNK) Up 28.5% Since Last Earnings Report: Can It Continue? Zacks -12.89%
06:45AM  Mallinckrodt plc Announces Final Results of Exchange Transactions PR Newswire
Dec-04-19 07:59AM  J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders Zacks +6.59%
Dec-02-19 07:20PM  Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-27-19 12:36PM  Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced MarketWatch +6.05%
09:37AM  Opioid Stocks Fall on News of Federal Criminal Investigation
08:42AM  Benzinga Pro's Stocks To Watch For Wednesday, Nov. 27th, 2019: DE, ADSK, GES, MNK, AMZN Benzinga
07:34AM  Fed Reportedly Opens Criminal Investigation on Opioid Makers Zacks
06:14AM  Pharma Companies Shares Tank As Feds Investigate Opioid Crisis Benzinga
Nov-26-19 01:21PM  Shares of opioid makers and distributors drop on criminal probe MarketWatch
07:08AM  Shares of generic drugmakers rise on hope that legal issues are nearing an end MarketWatch
06:45AM  Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease PR Newswire
Nov-25-19 12:49PM  Shares of generic drugmakers jump in morning trading MarketWatch +11.42%
12:39PM  Arnold Schneider Trims Positions in Chesapeake, Citigroup
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
07:00AM  Market Morning: GM Sues Fiat, Pharma Fights for Pricing Privacy, More Opioid Lawsuits, Trade Deal Troubles Market Exclusive
02:40AM  Edited Transcript of MNK earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-19-19 08:38PM  Mallinckrodt plc Announces Early Results of Exchange Transactions PR Newswire
06:45AM  Mallinckrodt to Present at Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-18-19 10:18PM  Value Investor Bill Millers New Stock Picks Insider Monkey
Nov-13-19 07:10AM  The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher Benzinga
Nov-12-19 04:30PM  Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting PR Newswire
Nov-11-19 03:30PM  Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019 PR Newswire -8.04%
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform, as well as Amitiza, a product for constipation. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; and SLN500, a ribonucleic acid technology therapy. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reasons Bryan M.EVP & CFOJun 07Buy8.965,40048,38317,979Jun 07 04:12 PM
Trudeau MarkPresident and CEOMay 30Buy9.262,00018,528233,254May 31 07:05 AM
Trudeau MarkPresident and CEOMay 09Buy16.331,00016,325231,254May 10 08:06 AM